Clinical Efficacy or Tildrakizumab in Patients With Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies. J of Skin 2018, 2 (S1), S4. https://doi.org/10.25251/skin.2.supp.4.